Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?

Invasive fungal infections are an important cause of morbidity and mortality, especially in critically ill patients. Increasing resistance rates and inadequate antifungal exposure have been documented in these patients, due to clinically relevant pharmacokinetic (PK) and pharmacodynamic (PD) alterat...

Descripción completa

Detalles Bibliográficos
Autores principales: Baracaldo-Santamaría, Daniela, Cala-Garcia, Juan David, Medina-Rincón, Germán José, Rojas-Rodriguez, Luis Carlos, Calderon-Ospina, Carlos-Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137962/
https://www.ncbi.nlm.nih.gov/pubmed/35625289
http://dx.doi.org/10.3390/antibiotics11050645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137962/
https://www.ncbi.nlm.nih.gov/pubmed/35625289
http://dx.doi.org/10.3390/antibiotics11050645

Ejemplares similares